Back to top

Image: Bigstock

New Strong Buy Stocks for June 18th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Cosan Limited (CZZ - Free Report) : This company that engages in fuel and natural gas distribution, logistics, lubricant, sugar, and ethanol businesses has seen the Zacks Consensus Estimate for its current year earnings increasing 16% over the last 60 days.

Cosan Limited Price and Consensus

 

Cosan Limited Price and Consensus

Cosan Limited price-consensus-chart | Cosan Limited Quote

Plains GP Holdings, L.P. (PAGP - Free Report) : This company that owns and operates midstream energy infrastructure has seen the Zacks Consensus Estimate for its current year earnings increasing 75.9% over the last 60 days.

Rio Tinto Group (RIO - Free Report) : This company that engages in finding, mining, and processing mineral resources has seen the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.

Rio Tinto PLC Price and Consensus

 

Rio Tinto PLC Price and Consensus

Rio Tinto PLC price-consensus-chart | Rio Tinto PLC Quote

Armstrong World Industries, Inc. (AWI - Free Report) : This company that designs, manufactures, and sells ceiling systems has seen the Zacks Consensus Estimate for its current year earnings increasing 2.9% over the last 60 days.

First Business Financial Services, Inc. (FBIZ - Free Report) : This company that provides commercial banking products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 10.7% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>